Stockscreener 앱 받기
7.00
0.14%
0.010
시간 외 거래:
7.00
전일 마감가:
$6.99
열려 있는:
$7
하루 거래량:
183.23K
Relative Volume:
0.85
시가총액:
$160.85M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-7.4468
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
-3.18%
1개월 성능:
+2.79%
6개월 성능:
+48.62%
1년 성능:
+278.38%
1일 변동 폭
$6.75
$7.05
1주일 범위
$6.62
$7.35
52주 변동 폭
$1.71
$7.95
Exagen Inc Stock (XGN) Company Profile
명칭
Exagen Inc
전화
(760) 560-1501
주소
1261 LIBERTY WAY, VISTA, CA
XGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.00 | 160.85M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
408.28 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.80 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
531.32 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.17 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
157.47 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-04-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cowen | Outperform |
| 2019-10-14 | 개시 | William Blair | Outperform |
모두보기
Exagen Inc 주식(XGN)의 최신 뉴스
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus
Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks
Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com
Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com
Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus
Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph
William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Exagen announces common stock offering, no amount given - TipRanks
Exagen Inc (XGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Exagen Inc 주식 (XGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
| Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
| ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
0.43%
0.70%
자본화:
|
볼륨(24시간):